[Federal Register Volume 63, Number 176 (Friday, September 11, 1998)]
[Notices]
[Pages 48737-48738]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-24370]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institutes of Health Clinical Center (NIHCC): 
Opportunity for Cooperative Research and Development Agreement (CRADA) 
in the Fields of Magnetic Resonance Imaging, Magnetic Resonance 
Spectroscopy, Molecular Imaging, Image Processing, and Surgery Under 
Image Guidance

AGENCY: Radiology Department, NIHCC, NIH, DHHS.

ACTION: Notice of CRADA Opportunity.

-----------------------------------------------------------------------

SUMMARY: The Radiology Department of the National Institutes of Health 
Clinical Center (NIHCC), seeks Cooperative Research and Development 
Agreements (CRADAs) with one or more medical equipment manufacturers to 
collaborate on research projects designed to develop improved 
technologies for radiological diagnosis and treatment. The term of the 
CRADA will be up to four (4) years.

DATES: Interested parties should submit a brief statement indicating: 
(i) area(s) of proposed research collaboration and (ii) interest in 
submitting a formal proposal. Statements of interest should be 
submitted to NIHCC in writing no later than December 10, 1998. Parties 
will then have an additional thirty (30) days in which to submit a 
formal proposal.

ADDRESSES: Inquiries and proposals regarding this opportunity should be 
addressed to Steve Galen, Technology Development Coordinator, National 
Institutes of Health, Warren Grant Magnuson Clinical Center, 6011 
Executive Boulevard, suite 559B, Rockville, MD 20852. Phone: (301) 594-
4509, FAX (301) 402-2143.

SUPPLEMENTARY INFORMATION: A CRADA is the anticipated joint agreement 
to be entered into by NIHCC pursuant to the Federal Technology Transfer 
Act of 1986 as amended by the National Technology Transfer Act (Pub.L. 
104-113 (Mar. 7, 1996)) and by Executive Order 12591 of April 10, 1987.
    The CRADA objective is the rapid publication of research findings 
and the timely commercialization of improved diagnostic and treatment 
strategies in

[[Page 48738]]

the fields of Magnetic Resonance Imaging, Magnetic Resonance 
Spectroscopy, Molecular Imaging, Image Processing, and Surgery Under 
Image Guidance. Particular emphasis is placed on discoveries that 
enhance clinical research.
    Under a CRADA, the NIHCC can offer selected collaborators access to 
facilities, staff, materials, and expertise. The collaborator may 
contribute facilities, staff, materials, expertise and funding to the 
collaboration. The NIHCC cannot contribute funding. The CRADA 
collaborator may elect an option to an exclusive or non-exclusive 
license to Government intellectual property rights arising under the 
CRADA and may qualify as a co-inventor of new technology developed 
under the CRADA.
    CRADA proposals will be evaluated under the following criteria:
     Corporate research and development competencies.
     Demonstrated abilities to productively collaborate in 
research programs.
     The nature of resources to be contributed to the 
collaboration.
     Key staff expertise, qualifications and relevant 
experience.
     Willingness to assign technical staff to on-site 
collaborative efforts.
     Ability to effectively commercialize new discoveries.

    Dated: August 26, 1998.
Kathleen Sybert,
Acting Director, Technology Development and Commercialization Branch, 
National Institutes of Health.
[FR Doc. 98-24370 Filed 9-10-98; 8:45 am]
BILLING CODE 4140-01-M